TriCor Tablet Replaces Lower Bioavailability Capsule; Abbott Adds HDL Claim
Executive Summary
Abbott is replacing TriCor capsules with tablets that show a higher bioavailability of fenofibrate.
You may also be interested in...
505(b)(2) Patent Certifications Attach To Reference Drug, Not Drug Substance
A 505(b)(2) NDA sponsor need only certify to patents for the reference listed drug product, not all patents associated with a drug substance, FDA said in rejecting an Abbott citizen petition regarding fenofibrate Nov. 30
505(b)(2) Patent Certifications Attach To Reference Drug, Not Drug Substance
A 505(b)(2) NDA sponsor need only certify to patents for the reference listed drug product, not all patents associated with a drug substance, FDA said in rejecting an Abbott citizen petition regarding fenofibrate Nov. 30
Reliant Will Add Antara, Omacor To Cardiovascular Product Line In 2005
Reliant will launch two recently-approved cardiovascular products, Antara and Omacor, in 2005